PK

Peterson Katharine

OFFICER

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-32.2%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the complete record of transactions filed by Peterson Katharine. Insider active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 6 reports have been recorded. Activity tracked since 14 May 2024. The latest transaction was disclosed on 14 November 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations6 total

●

Peterson Katharine

Chief Accounting OfficerExecutives14 Nov 2025Acrivon Therapeutics, Inc.

$22220SEC ↗

99 shares@ US$2.246.3% of flowCommon StockSEC:0000905148-25-004131:0

●

Peterson Katharine

Chief Accounting OfficerExecutives14 May 2025Acrivon Therapeutics, Inc.

$11319SEC ↗

99 shares@ US$1.143.3% of flowCommon StockSEC:0000905148-25-001824:0

●